• CEL-SCI closed a best-efforts public offering of 6,000,000 common shares priced at $1.2 per share.
• Gross proceeds totaled about $7.2 million.
• Net proceeds earmarked for continued development of Multikine, general corporate purposes, working capital.
• ThinkEquity served as sole placement agent.
• Shares were registered under Form S-1, effective May 11, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CEL-SCI Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20260513189882) on May 13, 2026, and is solely responsible for the information contained therein.